Advisory Board September 27, 2023
Darby Sullivan, Chloe Bakst

As more people take new weight-loss drugs, such as semaglutide, there are a growing number of reports of potential side effects, including severe mental health issues — leading drug regulators in Europe to investigate the safety of these drugs.

Are new weight-loss drugs leading to mental health issues?

Semaglutide mimics a hormone called glucagon-like peptide-1 (GLP-1) to targets areas of the brain that regulate appetite and food intake. The drug is available in two forms: Ozempic, a diabetes treatment, and Wegovy, a higher dose of the drug for weight loss.

As more people take semaglutide, there...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mental Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Survey / Study, Trends
Mental health organization taps Ascension executive as CEO
Where mental health ranks among Americans' healthcare priorities: 3 findings
Employers Reap $190 for Every $100 Invested in Behavioral Health
The growing movement to destigmatize mental health in nursing licensure
Little Otter Raises $9.5M for Family Mental Health

Share This Article